We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Chemoradiotherapy of NSCLC Stage IIIB

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00198432
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : March 10, 2016
Bristol-Myers Squibb
Pierre Fabre Laboratories
Ligue contre le cancer, France
Information provided by:
Intergroupe Francophone de Cancerologie Thoracique